Clinical trial
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and…
NCT00001238 · National Cancer Institute (NCI), NIH · Recruiting
Key facts
| NCT number | NCT00001238 |
|---|---|
| Title | Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders |
| Official title | Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Kidney Cancer, Urologic Malignant Disorders, Renal Cell Carcinoma, Familial Renal Cancer (FRC), Clear Cell Renal Cancer |
| Enrollment | 5,000 |
| Start date | Dec 5, 1990 |
| First posted | Nov 4, 1999 |
| Last update posted | Feb 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: